ORIX (IX) Reaches $96.10 52-Week High; Calamos Convertible Opportunities & Income Fund Has 1.25 Sentiment

January 14, 2018 - By Maria Brooks

The stock of ORIX Corporation (NYSE:IX) hit a new 52-week high and has $101.87 target or 6.00% above today’s $96.10 share price. The 5 months bullish chart indicates low risk for the $25.17 billion company. The 1-year high was reported on Jan, 14 by Barchart.com. If the $101.87 price target is reached, the company will be worth $1.51 billion more. The stock increased 2.69% or $2.52 during the last trading session, reaching $96.1. About 149,134 shares traded or 455.85% up from the average. ORIX Corporation (NYSE:IX) has risen 13.83% since January 14, 2017 and is uptrending. It has underperformed by 2.87% the S&P500.

The stock increased 0.36% or $0.04 during the last trading session, reaching $11.25. About 183,431 shares traded. Calamos Convertible Opportunities and Income Fund (CHI) has risen 13.66% since January 14, 2017 and is uptrending. It has underperformed by 3.04% the S&P500.

ORIX Corporation provides financial services. The company has market cap of $25.17 billion. It operates through six divisions: Corporate Financial Services, Maintenance Leasing, Real Estate, Investment and Operation, Retail, and Overseas Business. It has a 9.33 P/E ratio. The Corporate Financial Services segment engages in lending, leasing, and fee businesses.

Camelot Portfolios Llc holds 0.61% of its portfolio in Calamos Convertible Opportunities and Income Fund for 109,272 shares. Vident Investment Advisory Llc owns 760,166 shares or 0.47% of their US portfolio. Moreover, E&G Advisors Lp has 0.33% invested in the company for 63,175 shares. The Switzerland-based Bellecapital International Ltd. has invested 0.24% in the stock. National Planning Corp, a California-based fund reported 69,132 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: